In other words, PTCH is an inhibitor leading to repression of Shh pathway activation, whereas basal cell carcinoma (BCC), featuring frequent loss of PTCH expression, can cause constitutive activation of the Shh pathway [88, 89]. Here, SHH is linked to skin basal cell carcinoma.